Loading…
Product type
Empagliflozin is an active pharmaceutical ingredient (API) used primarily in the treatment of type 2 diabetes. It belongs to the class of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, which work by preventing the reabsorption of glucose in the kidneys, thereby promoting its excretion in urine. This mechanism helps lower blood sugar levels in diabetic patients and can also contribute to weight loss and cardiovascular benefits. Empagliflozin is typically formulated in tablet form for oral administration.
| Chemical formula | C23H27ClO7S |
| Molecular weight | 450.97 g/mol |
| Purity | ≥ 98% |
| Solubility | Soluble in water and ethanol |
| Storage conditions | Store in a cool, dry place |
When purchasing empagliflozin, buyers should consider the required purity levels and ensure that the supplier can provide documentation for quality assurance. It's important to specify the desired quantity, as bulk orders may be necessary for large-scale pharmaceutical production. Additionally, inquire about any specific regulatory certifications or compliance with pharmacopoeial standards applicable to your region.
Get quotes for Empagliflozin
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
Empagliflozin is used to treat type 2 diabetes by lowering blood sugar levels.
It inhibits the SGLT2 protein in the kidneys, preventing glucose reabsorption.
Common side effects may include urinary tract infections, dehydration, and low blood sugar.
Long-term use is generally considered safe, but regular monitoring is recommended.
Yes, it can be used in combination with other diabetes medications as prescribed.
Consider purity, regulatory compliance, and supplier reliability.